Analyst Price Target is $6.00
▲ +341.18% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Enlivex Therapeutics in the last 3 months. The average price target is $6.00, with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 341.18% upside from the last price of $1.36.
Current Consensus is
Buy
The current consensus among 1 contributing investment analysts is to buy stock in Enlivex Therapeutics. This Buy consensus rating has held steady for over two years.